Skip to main content
. 2022 Apr 12;2(3):311–319. doi: 10.1016/j.jacasi.2021.10.010

Table 3.

Association of Clinical Variables With Annualized Total PVC and Plaque Progression

Annualized Total PVC
Plaque Progression
β (95% CI) SE P Value OR (95% CI) P Value
Age, per 1-y increase 0.448 (0.277 to 0.620) 0.087 <0.001 1.031 (1.014 to 1.048) <0.001
Male 2.523 (−0.847 to 5.894) 1.717 0.142 1.513 (1.102 to 2.077) 0.010
Hypertension 8.217 (4.846 to 11.588) 1.717 <0.001 1.778 (1.302 to 2.457) <0.001
Diabetes 6.691 (2.530 to 10.851) 2.120 0.002 1.557 (1.021 to 2.374) 0.040
Hyperlipidemia 1.235 (−2.370 to 4.839) 1.836 0.502 1.501 (1.056 to 2.134) 0.024
Overweight or obesity 4.081 (0.652 to 7.511) 1.747 0.020 1.470 (1.064 to 2.033) 0.020
Current smoking 4.472 (−0.023 to 8.967) 2.290 0.051 1.143 (0.743 to 1.757) 0.544
Creatinine, per 1 mg/dL increase 4.263 (1.714 to 6.811) 1.298 0.001 1.269 (0.788 to 2.043) 0.328
Hemoglobin, per 1 g/dL increase 0.644 (−0.371 to 1.658) 0.517 0.213 1.109 (1.012 to 1.215) 0.027
Δ Hemoglobin, per 1 g/dL increase −2.173 (−3.459 to −0.887) 0.655 0.001 0.868 (0.770 to 0.978) 0.020
Baseline total plaque volume, per-1 mm3 increase 0.073 (0.064 to 0.082) 0.005 <0.001 1.010 (1.007 to 1.012) <0.001

Δ hemoglobin = hemoglobin level changes; PVC = plaque volume changes.